The pathogenicity and future treatment strategies of Candida albicans
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1752304 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Jiadi Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Candida albicans, Antifungal Agents, Candidiasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candida albicans ( C. albicans ) is a major pathogenic fungus that severely impacts on human health. This review systematically elaborates on the key pathogenic processes of C. albicans , starting with its colonization, morphological transformation and biofilm formation under different carbon sources. The interaction between C. albicans and host immunity, including the role of PRRs, host genetics and immune polymorphisms, and trained immunity. Candidalysin regulating cAMP/PKA signaling pathway of C. albicans hyphae-biofilm transformation, the interaction between C. albicans and bacteria, as well as mucosal and invasive C. albicans infections, persister cells in anti- C. albicans therapy, emerging biology and pathogenicity aspects, epigenetic and chromatin regulation of host-drug adaptation, and strain-specific heterogeneity in pathogenicity, biofilm traits and drug susceptibility. Additionally, it summarizes novel therapeutic strategies, emphasizing probiotics and antimicrobial peptides (AMPs), and combination strategies with novel targeted therapy and traditional anti-fungal therapy to improve the survival of patients with Candida albicans infection. It systematically and comprehensively summarizes the pathogenicity of C. albicans and the possible therapeutic targets, providing new ideas for the development of novel antifungal drugs in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
- Guangzhou Institute of Cancer Research, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, China.
Zitieren
APA
Wu, J., Jiang, C., Wang, H., Chen, T., Chen, X., & Da, W. (2026). The pathogenicity and future treatment strategies of Candida albicans. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1752304
Vancouver
Wu J, Jiang C, Wang H, Chen T, Chen X, Da W. The pathogenicity and future treatment strategies of Candida albicans. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1752304
BibTeX
@article{Wu2026,
author = {Wu, Jiadi and Jiang, Chenyang and Wang, Hui and Chen, Tongbin and Chen, Xi and Da, Wenyue},
title = {The pathogenicity and future treatment strategies of Candida albicans},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1752304}
}
EUVIMED